To provide a comprehensive resource to companies, investors, and entrepreneurs
interested either in accessing China's market for antibody products or cost-effective
production of antibodies for therapeutic, diagnostic, or laboratory use.
Includes coverage of:
• Multinational company actions in China
• Therapeutic antibody market dynamics
Novel therapeutic antibodies in China's
pipeline
Innovative new drug developers
Generic antibody developers
• Diagnostic antibody market dynamics
Key competitors
Product trends
• Lab-use antibody market dynamics
China's growing domestic market
China's export oriented players
• Antibody services market dynamics
Key suppliers of antibody services
Pricing and cost trends
• Regulatory environment
Who benefits from this report?
• Managers and scientists
• Pharmaceutical companies
• Biotechnology companies
• Diagnostics companies
• Research institutes
• Distributors
• Investors
• Entrepreneurs
Why is this report unique?
• This report is the most comprehensive reference for China's antibody
industry
Methodology
• Face-to-face interviews and on-site visits
• Phone interviews with management
• Secondary research
|